Thomas C. Wessel

2011

In 2011, Thomas C. Wessel earned a total compensation of $1.4M as Chief Medical Officer at Acorda Therapeutics, a 143% increase compared to previous year.

Compensation breakdown

Option Awards$379,847
Salary$276,883
Stock Awards$420,310
Other$291,684
Total$1,368,724

Wessel received $420.3K in stock awards, accounting for 31% of the total pay in 2011.

Wessel also received $379.8K in option awards, $276.9K in salary and $291.7K in other compensation.

Rankings

In 2011, Thomas C. Wessel's compensation ranked 4,539th out of 10,747 executives tracked by ExecPay. In other words, Wessel earned more than 57.8% of executives.

ClassificationRankingPercentile
All
4,539
out of 10,747
58th
Division
Manufacturing
1,623
out of 3,960
59th
Major group
Chemicals And Allied Products
337
out of 1,033
67th
Industry group
Drugs
203
out of 781
74th
Industry
Biological Products, Except Diagnostic Substances
32
out of 157
80th
Source: SEC filing on April 26, 2012.

Wessel's colleagues

We found five more compensation records of executives who worked with Thomas C. Wessel at Acorda Therapeutics in 2011.

2011

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2011

Jane Wasman

Acorda Therapeutics

General Counsel

2011

Andrew Blight

Acorda Therapeutics

Chief Scientific Officer

2011

David Lawrence

Acorda Therapeutics

Chief Financial Officer

2011

Lauren Sabella

Acorda Therapeutics

Executive Vice President, Commercial Development

You may also like